Chemotherapy for Advanced Head and Neck Cancer
Author Information
Author(s): D. F. N. Harrison, W. N. Tucker
Primary Institution: Royal National Throat Nose and Ear Hospital
Hypothesis
Can chemotherapy improve the prognosis for patients with advanced cancer of the head and neck?
Conclusion
Chemotherapy using ethoglucid and cyclophosphamide can provide significant relief and even complete regression of tumors in some patients with advanced head and neck cancer.
Supporting Evidence
- 84% of the cases were squamous carcinomata.
- 32% of patients showed no improvement, while 30% experienced symptomatic relief.
- 12% of patients had complete regression of their tumors.
Takeaway
Doctors tried two medicines to help people with really bad throat and neck cancer, and some got better, even though it was very hard to treat.
Methodology
Eighty patients with advanced head and neck cancer were treated with two cytotoxic agents, ethoglucid and cyclophosphamide, from September 1961 to September 1963.
Potential Biases
Selection bias may exist as all patients had previously failed other treatments.
Limitations
The study does not provide long-term follow-up data and the sample includes patients who had previously received other treatments.
Participant Demographics
Patients ranged in age from 14 months to 82 years, with a majority over 60 years old.
Want to read the original?
Access the complete publication on the publisher's website